Plato Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Plato Investment Management's LLY Position: Q1 2026 in Review
Plato Investment Management increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $2.71M and bringing the position to 20,799 shares worth $19.1M. The position accounts for 1.29% of the portfolio, ranked #10.
Plato Investment Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $19.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Plato Investment Management held 20,799 shares of Eli Lilly worth $19.1M as of Q1 2026.
- Plato Investment Management bought 2,674 Eli Lilly shares in Q1 2026, an estimated $2.71M.
- Eli Lilly made up 1.29% of Plato Investment Management's portfolio in Q1 2026, its #10 holding.
- Plato Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- Plato Investment Management's Eli Lilly position peaked at $19.6M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.